News

  • bag briefcase passport

    ITEM researcher co-authors WODC study on migration of asylum permit holders

    01-11-2019

    On Thursday 10 October, a report concerning migration of asylum permission holders was published by the Research and Documentation Centre of the Ministry of Security and Justice (WODC) and Statistics Netherlands (CBS). This report is co-authored by Marloes de Hoon, a PhD candidate who is conducting research into mobility of refugees under the umbrella of the Institute for Transnational and Euregional cross border cooperation and Mobility (ITEM) at Maastricht University and affiliated to Statistics Netherlands. The report is co-authored with Arjen Leerkes, professor at Maastricht University and research fellow at WODC.

  • ITEM ICGI Cross-border corporate mobility CbCM featured

    Third report on corporate mobility in the EU published

    27-06-2019

    The third report of the ITEM/ICGI project on ‘Cross-Border Corporate Mobility in the EU’ has now been published. The report builds upon the earlier reporting on cross-border corporate activity and features a comprehensive country-by-country reporting to provide a fuller picture of cross-border company mobility in the EU.

  • Childcare allowance for each PhD candidate

    20-03-2019

    It has appeared in several cases already: PhD candidates with a scholarship who do not receive childcare allowance. Recently, Minister Van Engelshoven of Education, Culture and Science answered parliamentary questions about the right to childcare allowance for PhD candidates. The answers she gives are in line with the well-known arguments of the Dutch Tax Administration. Expertise centre ITEM questions these arguments on the basis of European law.

  • World Cancer Day

    Proton therapy: looking for the ‘how?’

    04-02-2019

    This year, the MAASTRO clinic in Maastricht is starting to use proton therapy - the promising new form of radiation treatment for cancer. The ‘what and why’ are no longer in question. Irradiation with protons instead of with photons can make a big difference for some types of cancer. The biggest question now revolves around the ‘how’.

Subscribe to News